The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; none of the 2 sources its claims cite is checked for support yet.
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Open accessAbstract
The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death. BCL2 was isolated from the chromosomal breakpoint of follicular B-cell lymphoma. Transgenic mice that overexpress BCL2 display extended survival of resting B cells. In this study we use a monospecific anti-human BCL2 antibody to define the distribution of BCL2 protein within organized tissues. BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells. BCL2 is present in the surviving T cells in the thymic medulla. All hematopoietic lineages that derive from a renewing stem cell also display BCL2. A limited number of nonlymphoid tissues demonstrate BCL2 and can be grouped as (i) glandular epithelium in which hormones or growth factors regulate hyperplasia and involution, (ii) complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells, and (iii) long-lived postmitotic cells such as neurons. Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones. BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Using a monospecific anti-human BCL2 antibody, the authors map BCL2 protein across organized tissues and find it topographically restricted to long-lived or proliferating zones in tissues with apoptotic turnover. BCL2 is present in selected lymphoid, hematopoietic, glandular epithelial, complex epithelial, and postmitotic neuronal compartments.
Key findings
- Within germinal centers, BCL2 is restricted to the follicular mantle and portions of the light zone implicated in selection and maintenance of plasma cells and memory B cells.
- BCL2 is present in surviving T cells in the thymic medulla and in all hematopoietic lineages derived from a renewing stem cell.
- A limited set of nonlymphoid tissues shows BCL2: glandular epithelium regulated by hormones/growth factors, complex differentiating epithelium such as skin and intestine with long-lived stem cells, and long-lived postmitotic cells such as neurons.
- In tissues with apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones; the authors suggest BCL2 may confer longevity to progenitor and effector cells.
Methods
- The study uses a monospecific anti-human BCL2 antibody to define BCL2 protein distribution within organized tissues.
- The provided text does not report sample sizes, tissue sources, staining protocols, or quantitative analysis details.
Limitations
- The paper’s abstract does not state limitations.
- Evident from the provided text: only the abstract and reference list are available, so sample composition, antibody specificity controls, quantification, and full results cannot be assessed. No quantitative values are reported in the provided text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Own interpretation · 4 Own result · 2 No full text of the sources · 1 No basis given
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“All hematopoietic lineages that derive from a renewing stem cell also display BCL2.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is present in the surviving T cells in the thymic medulla.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A limited number of nonlymphoid tissues demonstrate BCL2”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glandular epithelium in which hormones or growth factors regulate hyperplasia and involution”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“long-lived postmitotic cells such as neurons”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
In the paper
“Transgenic mice that overexpress BCL2 display extended survival of resting B cells.”
What the sources say
- Not checked — no full text of the sourcecites McDonnell et al., 1989 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
- It may state two separate claims as one. 1
In the paper
“The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death.”
What the sources say
- Not checked — no full text of the sourcecites Hockenbery et al., 1990 source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
The anti-human BCL2 antibody used in this study is monospecific for BCL2.
“we use a monospecific anti-human BCL2 antibody”
Citations
Cites
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,673
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Self-citationBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D., Cory, S., & Adams, J. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,355
Cheng, H., & Leblond, C. P. (1974) · American Journal of Anatomy · doi:10.1002/aja.1001410407 · Cited by 1,737
Savill, J. S., Wyllie, A. H., Henson, J. E., Walport, M. J., Henson, P. M., & Haslett, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113970 · Cited by 1,536
Cohen, J., & Duke, R. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.38 · Cited by 1,406
Regressive Events in Neurogenesis
Cowan, W. M., Fawcett, J. W., O'Leary, D. D. M., & Stanfield, B. B. (1984) · Science · doi:10.1126/science.6474175 · Cited by 1,316
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
Self-citationCleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,212
Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L., & Korsmeyer, S. J. (1985) · Cell · doi:10.1016/s0092-8674(85)80070-2 · Cited by 1,177
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,244
Rossiter, H., Beissert, S., Mayer, C. L., et al. (2001) · PubMed · Cited by 33
The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo
Bruckheimer, E. M., Cho, S., Brisbay, S. M., Johnson, D. J., Gingrich, J. R., Greenberg, N. M., & McDonnell, T. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203571 · Cited by 32
“In normal prostate, bcl-2 expression is restricted to the basal cells of the glandular epithelium which are resistant to the e ects of androgen deprivation (Hockenbery et al., 1991).”
BackgroundPurification and characterization of fertility-associated antigen (FAA) in bovine seminal fluid
McCauley, T. C., Zhang, H., Bellin, M. E., & AX, R. L. (1999) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199910)54:2 · Cited by 56
Love, S., & Hilton, D. A. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199602)178:2 · Cited by 6
Expression and Replication Timing Patterns of Wildtype and Translocated BCL2 Genes
Sun, Y., Wyatt, R. T., Bigley, A., et al. (2001) · Genomics · doi:10.1006/geno.2000.6479 · Cited by 32
Riou, C., Tonoli, H., Bernier‐Valentin, F., Rabilloud, R., Fonlupt, P., & Rousset, B. (1999) · Endocrinology · doi:10.1210/en.140.5.1990 · Cited by 32
Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis
Cho, J.-H., & Kim, W. H. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80054-x · Cited by 32
Apoptosis, tumour invasion and prostate cancer
Tenniswood, M. (1997) · British Journal of Urology · doi:10.1111/j.1464-410x.1997.tb16918.x · Cited by 32
Givol, I., Tsarfaty, I., Resau, J. H., et al. (1994) · PubMed · Cited by 32
Dietary Non-nutritive Factors in Targeting of Regulatory Molecules in Colorectal Cancer: An Update
Pandurangan, A. K., & Esa, N. M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.10.5543 · Cited by 31
“For instance, Bcl-2 expression decreases upward along the crypts of normal colonic epithelium with the highest expression at the base and minimal amounts at the tip of the crypt (Hockenbery et al., 1991).”
BackgroundDistelhorst, C. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.020 · Cited by 31
Polyamine depletion inhibits irradiation-induced apoptosis in intestinal epithelia
Deng, W., Viar, M. J., & Johnson, L. R. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00564.2004 · Cited by 32
“much lower level than Bax in the small intestine (14), a definite”
BackgroundHartmann, S., Eray, M., Döring, C., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-332 · Cited by 31
“One of these features may represent enhanced tonic active B cell receptor signaling [23-25] or the upregulation of BCL2 anti-apoptotic protein [26,27].”
BackgroundO’Reilly, M. A., Stripp, B. R., & Pryhuber, G. (1997) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19970901)38:5 · Cited by 24
Pablos, J. L., Carreira, P. E., Serrano, L., del Castillo, P., & Gómez-Reino, J. J. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500509 · Cited by 31
“Bcl-2 has been previously detected in vivo in embryonic but not adult fibroblasts (Polakowska et al. 1994; Hockenbery et al. 1991).”
BackgroundRamakrishnan, M., Liu, W.-M., DiCroce, P. A., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.868-877.2000 · Cited by 31
“The t(14,18) translocation of human follicular lymphoma activates the oncogene BCL2 (22, 25) and aborts programmed cell death (11, 12 , 18).”
BackgroundOrelio, C. C., Harvey, K. N., Miles, C. G., Oostendorp, R. A. J., van der Horn, K., & Dzierzak, E. A. (2004) · Blood · doi:10.1182/blood-2003-06-1827 · Cited by 31
Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma
Nakopoulou, L., Stefanaki, K. S., Vourlakou, C., Manolaki, N., Gakiopoulou, H., & Michalopoulos, G. K. (1999) · Pathology - Research and Practice · doi:10.1016/s0344-0338(99)80089-2 · Cited by 31
Molecular biology of prostate cancer
Shi, X., Gumerlock, P. H., & White, R. D. (1996) · World Journal of Urology · doi:10.1007/bf00184605 · Cited by 31
Zhan, Q., Signoretti, S., Whitaker‐Menezes, D., et al. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700583 · Cited by 30
Egido, J. (1996) · Frontiers in bioscience · doi:10.2741/a114 · Cited by 30
Hu, Y., Bebb, G. D., Tan, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1036 · Cited by 30
Quinn, Ostrowski, Harkins, et al. (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00505.x · Cited by 30
“Expression of the bcl-2 protein product has been documented in a variety of normal human tissues including breast epithelium.(2,3) bcl-2 protein is also expressed in invasive breast carcinoma and is associated with good histological grade and positive oestrogen receptor (ER) status.”
BackgroundRepair After Acute Lung Injury
Bitterman, P. B., Polunovsky, V. A., & Ingbar, D. H. (1994) · CHEST Journal · doi:10.1378/chest.105.3_supplement.118s · Cited by 30
Biochemical Properties of Human Oral Polymorphonuclear Leukocytes
Nakahara, H., Sato, E. F., Ishisaka, R., et al. (1998) · Free Radical Research · doi:10.3109/10715769809066886 · Cited by 30
Törmänen, U., Nuorva, K., Soini, Y., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690159 · Cited by 30
“In normal skin, bcl-2 is expres in the basal epithelial cells (Hockenbery et al, 1991; Lu e 1993).”
BackgroundTesfaigzi, Y., Hotchkiss, J. A., & Harkema, J. R. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.18.6.3036 · Cited by 30
“Hockenbery and colleagues (9) have reported ( Received in original form May 28, 1997 and in revised form September 16,”
BackgroundRegulation of S100P expression by androgen
Averboukh, L., Liang, P., Kantoff, P. W., & Pardee, A. B. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199612)29:6 · Cited by 85
Fas Antigen (CD95) and Hematopoietic Progenitor Cells
Nagafuji, K., Takenaka, K., Shibuya, T., et al. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609045713 · Cited by 30
Tao, J., Liu, Z., Wang, Y., et al. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.032 · Cited by 29
Signaling Pathways That Control Apoptosis in Prostate Cancer
Ali, A. A., & Kulik, G. (2021) · Cancers · doi:10.3390/cancers13050937 · Cited by 34
“In the mid to late 90s several groups assessed the roles of BCL2 protein in apoptosis induced in prostate epithelial cells by androgen ablation [76,77].”
BackgroundLiang, S., Chen, S., Ren, C., et al. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111358 · Cited by 29
Immunohistochemical Study on Fas and Fas Ligand in Skin Wound Healing
Guan, D., Ohshima, T., & Kondo, T. (2000) · The Histochemical Journal · doi:10.1023/a:1004058010500 · Cited by 29
Bostwick, D. G., & Meiers, I. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-01970-5.50011-7 · Cited by 29
Impact of Bcl-2 and Ha-ras on Keratinocytes in Organotypic Culture
Delehedde, M., Cho, S. H., Hamm, R. L., Brisbay, S. M., McDonnell, T. J., Ananthaswamy, H. N., & Kripke, M. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01260.x · Cited by 29
Lambrechts, A. C., Looijenga, L. H. J., Veer, M. B. V., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.15 · Cited by 29
Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer
Silvestrini, R., Costa, A., Lequaglie, C., et al. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050188 · Cited by 29
Origin of hyperplastic epithelial cells in idiopathic collapsing glomerulopathy
Kihara, I., Yaoita, E., Kawasaki, K., et al. (1999) · Histopathology · doi:10.1111/j.1365-2559.1999.00670.x · Cited by 29
Spontaneous liver tumors and Benzo[a]pyrene-induced lymphomas in XPA-deficient mice
de Vries, A., van Oostrom, C. T. M., Dortant, P. M., Beems, R. B., van Kreijl, C. F., Capel, P. J., & STEEG, H. V. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199705)19:1 · Cited by 83
Schuhmann, D., Godoy, P., Weiß, C., et al. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04250.x · Cited by 28
Chattopadhyay, G., Khan, A. Q., Sen, G., Colino, J., Dubois, W., Rubtsov, A. V., Torres, R. M., Potter, M., & Snapper, C. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7523 · Cited by 28
“Bcl-2 is then down-regulated in B cells within the germinal center (GC), the key site for the generation of memory B cells (17), where extensive apoptosis occurs (18, 19).”
BackgroundTsamandas, A. C., Kardamakis, D. M., Petsas, T. G., et al. (2007) · PubMed · Cited by 28
Wu, C., Hu, S., Cheng, J., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4282 · Cited by 28
“The anti-apoptotic gene Bcl-2 is well known for its critical role in regulating cell cycle and death (25).”
Albertine, K. H., & Plopper, C. G. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.4.f236 · Cited by 28
Apoptotic and proliferative markers in chordomas: A study of 26 tumors
Kilgore, S. P., & Prayson, R. A. (2002) · Annals of Diagnostic Pathology · doi:10.1053/adpa.2002.35397 · Cited by 28
Atuğ, F., Türkeri, L., Özyürek, M., et al. (1998) · International Urology and Nephrology · doi:10.1007/bf02550226 · Cited by 28
“There have been multiple studies which had shown that this protein blocks apoptosis [6, 12-17].”
BackgroundYokochi, T., Kato, Y., Sugiyama, T., et al. (1996) · FEMS Immunology & Medical Microbiology · doi:10.1016/0928-8244(96)00035-1 · Cited by 28
Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue
Kojima, M., Morisaki, T., Tsukahara, Y., Uchiyama, A., Matsunari, Y., Mibu, R., & Tanaka, M. (1999) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199904)70:4 · Cited by 118
Drenning, S. D., Marcovitch, A. J., Johnson, D. E., et al. (1998) · PubMed · Cited by 28
Gillardon, F., Wickert, H., & Zimmermann, M. (1994) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1994.tb00555.x · Cited by 28
Marthinuss, J., Lawrence, L., & Seiberg, M. (1995) · PubMed · Cited by 28
Jia, Y., Wang, F., Gao, Y., Qin, H., & Guan, C. (2023) · Aquatic Toxicology · doi:10.1016/j.aquatox.2023.106502 · Cited by 31
Differential expression of Bcl‐2, Bcl‐XL and p53 in colorectal cancer
Han, H. S., Park, Y., & Hwang, T. S. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04325.x · Cited by 27
Do T cells care about the mitogen‐activated protein kinase signalling pathways?
Rincón, M., Conze, D. B., Weiss, L., Diehl, N. L., Fortner, K. A., Yang, D. D., Flavell, R. A., Enslen, H., Whitmarsh, A. J., & Davis, R. J. (2000) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2000.00900.x · Cited by 27
Merkel cells and Merkel cell carcinoma express the BCL‐2 proto‐oncogene
Plettenberg, A., Pammer, J., & Tschachler, E. (1996) · Experimental Dermatology · doi:10.1111/j.1600-0625.1996.tb00114.x · Cited by 27
Thrombopoietin and the TPO receptorduring platelet storage
Xia, Y., Li, J., Bertino, A. M., et al. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40080976.x · Cited by 27
Apoptosis and its clinical significance for bladder cancer therapy
Kelly, J. D., Williamson, K., Irvine, A. E., Hamilton, P. W., Weir, H. P., Anderson, N. H., Keane, P. F., & Johnston, S. R. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00871.x · Cited by 27
Bcl-2 Expression in Langerhans' Cell Histiocytosis
Savell, V. H., Sherman, T. S., Scheuermann, R. H., Siddiqui, A. M., & Margraf, L. R. (1998) · Pediatric and Developmental Pathology · doi:10.1007/s100249900028 · Cited by 26
Regulation of survival pathways by IL-3 and induction of apoptosis following IL-3 withdrawal
Johnson, D. E. (1998) · Frontiers in bioscience · doi:10.2741/a276 · Cited by 27
“In the adult, Bcl-2 is expressed in bone marrow progenitor cells representing all lineages, suggesting a role in the survival of these immature cells (62).”
BackgroundRosenthal, D. S., Simbulan-Rosenthal, C. M., Liu, W. F., et al. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9109 · Cited by 27
Molecular biology of prostate carcinogenesis
Lara, P. N. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00041-4 · Cited by 27
Penault-Llorca, F. M., Bouabdallan, R., Devilard, É., et al. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80114-3 · Cited by 27
Human Astrocytomas Co-expressing Fas and Fas Ligand also Produce TGFβ2 and Bcl-2
Frankel, B. M., Longo, S. L., & Ryken, T. C. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006311231189 · Cited by 27
“In the normal adult nervous system, Bcl-2 is present in neurons but absent in glial cells [36].”
BackgroundMu, J., Kanzaki, T., Si, X., Tomimatsu, T., Fukuda, H., Shioji, M., Murata, Y., Sugimoto, Y., & Ichikawa, A. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.008029 · Cited by 26
“Overexpression of Bax promotes apoptotic cell death, and conversely, Bcl-2 promotes this type of cell survival [15, 16].”
BackgroundWang, W., Lin, J., Wu, C., Luo, A.-L., Xing, X., & Xu, L. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad558 · Cited by 26
Expression of bcl-2 in Enteric Neurons in Normal Human Bowel and Hirschsprung Disease
Wester, T., Olsson, Y., & Olsen, L. (1999) · Archives of Pathology & Laboratory Medicine · doi:10.5858/1999-123-1264-eobien · Cited by 26
Scopa, C. D., Tsamandas, A. C., Zolota, V., et al. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1026178506348 · Cited by 26
Bcl-2 Family Proteins and the Hormonal Control of Cell Life and Death in Normalcy and Neoplasia
Reed, J. C. (1997) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60705-0 · Cited by 26
Role of the bcl-2 Gene after Contusive Spinal Cord Injury in Mice
Seki, T., Hida, K., Tada, M., Koyanagi, I., & Iwasaki, Y. (2003) · Neurosurgery · doi:10.1227/01.neu.0000068988.28788.2c · Cited by 26
“Normal glial cells in vivo do not seem to express Bcl-2 (11, 19), but reactive astrocytes around intracerebral lesions exhibit moderate Bcl-2 immunostaining (25).”
BackgroundUpregulation of Bcl‐2 protein in the myasthenic thymus
Onodera, J., Nakamura, S., Nagano, I., et al. (1996) · Annals of Neurology · doi:10.1002/ana.410390414 · Cited by 26
Boix, J., Fibla, J., Yuste, V. J., et al. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3852 · Cited by 26
Aprikian, A. G., Han, K., Guy, L., Landry, F., Bégin, L. R., & Chevalier, S. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(1998)8+ · Cited by 68
Genetically engineering mammalian cell lines for increased viability and productivity
Mosser, D. D., & Bernard Massie, B. (1994) · Biotechnology Advances · doi:10.1016/0734-9750(94)90013-2 · Cited by 26
Keratoacanthoma and squamous cell carcinoma: study of PCNA and LeY expression
Tsuji, T. (1997) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1997.tb00815.x · Cited by 26
Creating a New Cancer Therapeutic Agent by Targeting the Interaction between Bcl-2 and IP3ReceptorsPreprint
Distelhorst, C., & Bootman, M. D. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a035196 · Cited by 26
Dina, R. E., Marchetti, C., Vallania, G., et al. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80103-8 · Cited by 25
Is Dupuytren’s Disease Caused by an Imbalance between Proliferation and Cell Death?
Jemec, B., Grobbelaar, A. O., Wilson, G. D., et al. (1999) · Journal of Hand Surgery (European Volume) · doi:10.1054/jhsb.1999.0251 · Cited by 25
“A number of tissues, however, lack bcl-2, such as liver, lung, heart, kidney, cervix, myometrium, testis, ovary and bladder (Hockenberry et al., 1991) and Dupuytren's tissue.”
BackgroundHaematopoietic response and bcl‐2 expression in patients with acute myeloid leukaemia
Bincolettu, C., Saad, S. T. O., da Silva, E. S., et al. (1999) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1999.tb01112.x · Cited by 25
The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood
Claviez, A., Tiemann, M., Peters, J. H., et al. (1994) · Annals of Hematology · doi:10.1007/bf01715132 · Cited by 25
“Evidence exists that cell lines transfected with the bcl-2 gene acquire the ability to survive in the absence of otherwise essential growth factors [24].”
BackgroundMolecular interactions between G-actin, DNase I and the beta-thymosins in apoptosis: a hypothesis
Hall, A. K. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90135-x · Cited by 25
Ziv, I., Offen, D., Barzilai, A., et al. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_20 · Cited by 25
Pierelli, L., Scambia, G., Fattorossi, A., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00885.x · Cited by 25
“Haemopoietic progenitor cells express the anti-apoptotic protein bcl-2 during the early stages of haemopoiesis, whereas bcl-2 expression is down-regulated upon cellular differentiation (Hockenbery et al, 1991).”
BackgroundReed, D. S., Romero, P. J., Rimoldi, D., Cerottini, J., Schaack, J. B., & Jongeneel, C. V. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970917)72:6 · Cited by 10
Bull sperm head morphometry related to abnormal chromatin structure and fertility
Sailer, B. L., Jost, L. K., & Evenson, D. P. (1996) · Cytometry · doi:10.1002/(sici)1097-0320(19960601)24:2 · Cited by 148
Marzano, A. V., Frezzolini, A., Caproni, M., et al. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000313 · Cited by 24
Boshra, V., & Atwa, A. (2016) · Physiology International · doi:10.1556/2060.103.2016.3.2 · Cited by 22
Peherstorfer, E., Mayer, B., Boehm, S., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00317.2001 · Cited by 24
“As the Bcl-2 protein is expressed especially in long-lived cells and/or proliferating cell zones (13), it is not surprising that it is also found in human renal proximal tubule cells (29).”
BackgroundBabu, P., Suzuki, G., Ono, Y., & Yoshida, Y. (2004) · Pathology international (Print) · doi:10.1111/j.1440-1827.2004.01767.x · Cited by 24
Stasi, R., Amadori, S., Newland, A. C., & Provan, D. (2005) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400027829 · Cited by 24
Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780
Lim, K. B., Ng, C. Y., Ong, C. K., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1011929222555 · Cited by 24
Hindermann, W., Berndt, A., Wunderlich, H., et al. (1997) · Pathology - Research and Practice · doi:10.1016/s0344-0338(97)80088-x · Cited by 24
Flow cytometric analysis of apoptosis and BCL‐2 in human solid neoplasms
Steck, K. D., McDonnell, T. J., & El‐Naggar, A. K. (1995) · Cytometry · doi:10.1002/cyto.990200208 · Cited by 24
Cholangiocytic apoptosis in chronic ductopenic rejection
Koukoulis, G. Κ., Shen, J., Karademır, S., Jensen, D., & Williams, J. M. (2001) · Human Pathology · doi:10.1053/hupa.2001.26465 · Cited by 23
Haarman, E. G., Kaspers, G. J. L., Pieters, R., et al. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4811-9_35 · Cited by 24
Ilyas, M., Tomlinson, I. P. M., Hanby, A. M., et al. (1996) · PubMed · Cited by 24
Ito, M., Watanabe, M., Ihara, T., et al. (1995) · Cellular Immunology · doi:10.1016/0008-8749(95)80024-d · Cited by 24
Antigen retrieval for bcl‐2 protein in formalin‐fixed, paraffin‐embedded sections
Umemura, S., Kawai, K., OSAMURA, R. Y., et al. (1995) · Pathology International · doi:10.1111/j.1440-1827.1995.tb03429.x · Cited by 24
Anti-apoptotic gene Bcl2 is required for stapes development and hearing
Carpinelli, M. R., Wise, A. K., Arhatari, B. D., Bouillet, P., Manji, S. S. M., Manning, M. G., Cooray, A. A., & Burt, R. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.100 · Cited by 23
“Bcl2 is widely expressed in neurons in human foetuses and adults and is also expressed in foetal cochlear hair cells.(6,8) We hypothesised that the hearing loss in Bcl2 / mice may be due to premature apoptosis of cochlear hair cells or”
Molecular analysis of oral squamous cell carcinoma: A tissue microarray study
Solomon, M. C., Carnelio, S., & Guddattu, V. (2010) · Indian Journal of Cancer · doi:10.4103/0019-509x.63013 · Cited by 23
Biomarkers of potential prognostic significance in diffuse large B‐cell lymphoma
Wu, G., & Keating, A. (2005) · Cancer · doi:10.1002/cncr.21586 · Cited by 23
“Increased bcl-6 expression.(40,41) 20-30%.”
Metadata
- Authors
- Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1991-08-15
- Volume
- 88
- Issue
- 16
- Pages
- 6961-6965
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC52213
- OpenAlex
- W1970629830
- Semantic Scholar
- d825dc162ad208c572711f59c9aa1c7974e89492
- Cited by
- 1,252
- References
- 40
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 15 · 2013: 10 · 2012: 12
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2, apoptosis, germinal center, light zone, plasma cells, memory B cells, thymic medulla, hematopoietic stem cells, tissue distribution, epithelial stem cells, follicular B-cell lymphoma, transgenic mice
- MeSH terms
- Adult, Bone Marrow, Breast, Cell Survival, Digestive System, Female, Humans, Immunoenzyme Techniques, Male, Neurons, Pancreas, Prostate, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Proto-Oncogenes, Skin, Thymus Gland, Palatine Tonsil, Proto-Oncogene Proteins c-bcl-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
